tiprankstipranks
Trending News
More News >
Finch Therapeutics Group, Inc. (FNCH)
:FNCH
US Market

Finch Therapeutics Group (FNCH) Income Statement

Compare
62 Followers

Finch Therapeutics Group Income Statement

Last quarter (Q2 2024), Finch Therapeutics Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Finch Therapeutics Group's net income was $-4.83M. See Finch Therapeutics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 107.00K$ 861.00K$ 18.53M$ 7.72M$ 10.15M
Gross Profit
$ -1.41M$ -4.65M$ -38.75M$ -25.43M$ 9.84M
Operating Expenses
$ 32.59M$ 90.47M$ 78.52M$ 47.16M$ 30.98M
Depreciation and Amortization
$ 1.52M$ 5.51M$ 2.30M$ 790.00K$ 482.00K
EBITDA
$ -32.48M$ -82.69M$ -57.68M$ -38.65M$ -20.66M
Operating Income
$ -34.00M$ -95.12M$ -59.98M$ -39.44M$ -21.14M
Other Income/Expenses
$ -44.21M$ -19.53M$ 1.82M$ 95.00K$ 388.00K
Pretax Income
$ -78.22M$ -114.65M$ -58.16M$ -39.34M$ -20.75M
Net Income
$ -74.75M$ -114.65M$ -58.16M$ -39.25M$ -20.75M
Per Share Metrics
Basic EPS
$ -46.59$ -72.12$ -36.72$ -24.39$ -12.68
Diluted EPS
$ -46.59$ -72.12$ -36.72$ -24.39$ -12.68
Weighted Average Shares Outstanding
1.60M 1.59M 1.58M 1.61M 1.61M
Weighted Average Shares Outstanding (Diluted)
1.60M 1.59M 1.58M 1.61M 1.61M
Currency in USD

Finch Therapeutics Group Earnings and Revenue History